DNA Testing News: Breaking DNA Testing News, Comments and Articles. - Page: 3

Targeting High-Risk Neighborhoods May Eliminate Tuberculosis

Identifying specific neighborhoods that have a high incidence of tuberculosis followed by testing and treating the residents proved to eliminate those communities’ cases of tuberculosis, according to new research published in the American Journal of Public Health. A latent tuberculosis infection, called LTBI, accounts for the development of most

Molecular roots of cocaine addiction in brain uncovered: Promising new anti-addiction drug revealed

Researchers have unraveled the molecular foundations of cocaine’s effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe for humans, is undergoing further animal...

Increasing HIV Testing Among Male Partners of Pregnant Women

Couple-oriented posttest HIV counseling may increase HIV testing in the male partners of HIV-infected pregnant women. AIDS

Roche presents new, fully automated lab solution at Europe’s largest diagnostics conference

System improves efficiency and speed of blood sample testing in medical labs...

LabCorp Testing for Tuberculosis Diagnosis

The Nevada State Health Division is alerting physicians and healthcare workers of updated protocols regarding sputum samples being sent to LabCorp for tuberculosis diagnosis. State Health Alerts

LipoScience's Vantera® Clinical Analyzer To Provide Hospitals And Physicians With Lipoprotein Analysis For Cardiovascular Disease Management

RALEIGH, N.C., May 22, 2013 /PRNewswire/ -- LipoScience, Inc.,  (NASDAQ:  LPDX) a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care, today announced availability of NMR lipoprotein particle testing using the Vantera® Clinical Analyzer through Mayo Medical Laboratories. NMR lipoprotein...

Phagenesis Expands Series B Financing to $17 million

Manchester, UK – 22 May 2013 − Phagenesis, the world’s leading company in the treatment of dysphagia, has expanded its Series B financing to $17m. In 2011, Phagenesis announced a €7m Series B financing, led by Inventages Venture Capital. The increased resources will be used to launch the Phagenyx® treatment, which received its CE Mark in 2012, in new territories an...

Inexpensive, accurate way to detect prostate cancer: At-home urine tests

Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to new research.

Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors

NEW YORK, May 22, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs, today announced the appointment of June S. Almenoff, M.D., Ph.D., to its Board of Directors. Dr. Almenoff has extensive experience in the pharmaceutical industry, working on early and late stage drug development. "We...

Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

PHILADELPHIA and REHOVOT, Israel, May 22, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics, will deliver a corporate update at the Jefferies 2013 Healthcare Conference taking place from June 3-6, 2013 in New York City.&...

Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team

Express Diagnostics’ Australian and New Zealand distributor of DrugCheck® onsite testing devices, Royal Medical Supplies, has signed an agreement to sponsor V8 Supercar team Erebus Motorsport. The agreement involves each car of the team displaying the Royal Medical logo in Australian racing events. Blue Earth, MN (PRWEB) May 22, 2013 Express Diagnostics Int’l, Inc. (EDI), and Royal Medic...

Industry Leading Test Laboratory, BioScience Laboratories, Inc. Concludes Phase 1 Safety Evaluations in 12 Weeks, Exceeds Market Value, and Timeline, Again

BioScience Laboratories, Inc. Clinical Laboratory has again exceeded market standards for Phase 1 Dermatological Safety Studies for an IND submission. Phase I Dermatological Safety Studies represent a critical transition into the human model for every IND and ANDA submission. Bozeman, MT (PRWEB) May 22, 2013 BioScience Laboratories clinical laboratory has again exceeded market standards for Phase...

UK-Norwegian collaboration aims to develop a new living skin equivalent testing model for testing inflammatory responses.

Epistem, the UK biotechnology and personalized medicine company with expertise in skin biology and delivery of dermatological testing services, and ScandiDerma, a Norwegian company with expertise in developing new dermatological ingredients from biom...

Acadia, NPS, Ironwood sell more than $300m in stock

Large stock offerings by three publicly traded drug developers are testing the investor love affair with industry during a year in which the Nasdaq Biotechnology Index has skyrocketed 73% from 1094.71 on 3 January to 1893.44 as of 21 May. On.....

mumms® Software and Capital Caring Announce Collaborative Agreement

New Orleans, LA, May 22, 2013 --(PR.com)-- mumms® Software, a recognized innovator and developer of hospice and palliative care software, announced a collaborative agreement with Capital Caring, one of the oldest, largest and most experienced hospice and palliative care providers in the United States. A joint announcement was made in New Orleans at the recent Innovation Conference: MUMMS 20...

Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts

FARMINGTON, Conn. , May 22, 2013 /PRNewswire-iReach/ -- World markets are constantly changing and developing. To stay aligned with the latest trends and events, companies now need a global business intelligence provider that can predict where an ind...

Aviir Launches Complete Cardiovascular Genetic Testing

Care for Transgender Persons—Reply

In Reply: Dr Danoff and colleagues raise the issue of HIV testing in transgender care. Considering the data from the meta-analysis of 29 studies, it would be worthwhile for guidelines and review articles to mention the higher prevalence of HIV report...

Weight loss may reduce gout flares by suppressing inflammatory response

Obese patients with gout may benefit from undergoing bariatric surgery, as the resulting weight loss could help to reduce the frequency of their gout flares, new research suggests.Previous research has shown that weight loss only leads to a small reduction in concentrations of urate - which forms crystals in the joints of people with gout - yet can bring about a major reduction in gout flares.Scie...

Testing Diabetes Drug On Parkinson's Disease Patients

Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the progression of the disease....

Novel approach for influenza vaccination shows promise in early animal testing

(NIH/National Institute of Allergy and Infectious Diseases) A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and...

Scientists uncover molecular roots of cocaine addiction in the brain

(Johns Hopkins Medicine) Researchers at Johns Hopkins have unraveled the molecular foundations of cocaine's effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe...

Chemical Safety Improvement Act of 2013: PETA International Science Consortium

(People for the Ethical Treatment of Animals) Reform of chemical safety legislation will succeed only if it also modernizes toxicity testing.

A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK

Starkey Hearing Foundation Offers Assistance in Oklahoma

Foundation pledges hearing help to people affected by tornado Starkey Hearing Foundation is offering free assistance to those who may have suffered hearing loss or lost their hearing aids as a result of the devastating tornado around Oklahoma City on Monday. This is a time when many come together to extend caring hands. The reflected light of...